HPV16 E7 DNA tattooing: safety, immunogenicity, and clinical response in patients with HPV-positive vulvar intraepithelial neoplasia
Sanne Samuels(Centrum voor Gynaecologische Oncologie Amsterdam), Gemma G. Kenter(European Organisation for Research and Treatment of Cancer), Pia Kvistborg(The Netherlands Cancer Institute), John B.A.G. Haanen(Leiden University Medical Center), Joost H. van den Berg(The Netherlands Cancer Institute), Ekaterina S. Jordanova(Centrum voor Gynaecologische Oncologie Amsterdam), Sjoerd H. van der Burg(Leiden University Medical Center), Marc van Beurden(Oncode Institute), A. Marijne Heeren(Academic Center for Dentistry Amsterdam), Marij J.P. Welters(Leiden University Medical Center), Ilina Ehsan(Leiden University Medical Center), Suzy Scholl(Institut Curie), Bastiaan Nuijen(The Netherlands Cancer Institute), Ton N. Schumacher(Leiden University Medical Center), Henry Zijlmans(Leiden University Medical Center), Daisy Philips(The Netherlands Cancer Institute)
Cited by 19
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma
|New England Journal of Medicine|2019|1.4k
Therapeutic cancer vaccines
|Journal of Clinical Investigation|2015|1.1k